Validating the use of napsin A as a marker for identifying tumorigenic potential of lung bronchiolo-alveolar hyperplasia in rodents
- 1 October 2017
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 69 (8) , 637-642
Abstract
No abstract availableKeywords
Funding Information
- Grants-in-Aid for Chemical Risk Research
This publication has 14 references indexed in Scilit:
- Napsin A is possibly useful marker to predict the tumorigenic potential of lung bronchiolo-alveolar hyperplasia in F344 ratsExperimental and Toxicologic Pathology, 2014
- Nanosized zinc oxide particles do not promote DHPN-induced lung carcinogenesis but cause reversible epithelial hyperplasia of terminal bronchioles.Archives of Toxicology, 2013
- Applications and Limitations of Immunohistochemical Expression of “Napsin-A” in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other OrgansApplied Immunohistochemistry & Molecular Morphology, 2013
- IMP3 can predict aggressive behaviour of lung adenocarcinomaDiagnostic Pathology, 2012
- The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomasCancer Cytopathology, 2010
- Proliferative and Nonproliferative Lesions of the Rat and Mouse Respiratory TractToxicologic Pathology, 2009
- Lung Carcinogenic Bioassay of CuO and TiO2 Nanoparticles with Intratracheal Instillation Using F344 Male RatsJournal of Toxicologic Pathology, 2009
- Pituitary HyperplasiaHormones, 2003
- Investigation into the effect of DHEA on renal carcinogenesis induced in the rat by a single dose of DMNNutrition and Cancer, 1990
- Enhancement of N-bis(2-hydroxypropyl)nitrosamine-initiated lung tumor development in rats by bleomycin and N-methyl-N-nitrosourethaneCancer Letters, 1984